Stock Analiz

Uranium Royalty Corp. UROY

Investment Bankers/Brokers/Service · data as of November 13, 2026

$2.78Market cap $1.0B
Open the interactive analysis →

Uranium Royalty Corp. (UROY) is a financial company listed in the US with a market value of about $1.0B. In the twelve months to July 31, 2026 it had revenue of $214M and net income of $55M, a net margin of 25.9%.

Its overall Stock Analiz score is 2.2 out of 5 (weak). The strongest part is value (4/5); the weakest is track record (0/5).

Key numbers: a P/E of 7.3, a price to free cash flow of 5.0, a 5-year average ROIC of 4%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 115% above the current price.

Score: 2.2 / 5

Value4/5
Future growth3/5
Track record0/5
Financial health3/5
Shareholder returns1/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • Revenue growth above 10% last year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • Positive free cash flow

Checks not passed

  • PEG below 1.5
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year revenue growth above 8% a year
  • 5-year average ROIC above 12%
  • Profitable 5 years in a row
  • ROE above 15%

Valuation

P/E (TTM)7.3
Forward P/E—
P/FCF5.0
P/S4.9
P/B1.1
EV/EBITDA24.9
PEG—
Dividend yield0.00%
FCF yield19.8%
Shareholder yield0.0%
Intrinsic value vs. price+115%

Growth and quality

Revenue growth (1 yr)1566.0%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)8.4%
ROIC (5-yr avg.)4.0%
Profitable years (of last 10)2
Years paying a dividend—

Financials, last 3 years

Fiscal yearTTM202620252024
Revenue$214M$187M$11M$31M
Net income$55M$40M-$5M$14M
Free cash flow$208M———
EPS (diluted)$0.38$0.29$-0.04$0.12
Net margin25.9%21.6%-40.2%43.9%
ROIC—11.4%-1.3%2.1%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 3 analysts is $4.31, 55% above the current price; targets range from $3.95 to $4.50; the consensus rating is “none”; expected EPS is $0.11 for the fiscal year ending April 30, 2027.

Frequently asked questions

What is Uranium Royalty’s P/E ratio?

About 7.3, based on the last twelve months of diluted earnings per share.

Is Uranium Royalty stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 115% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Uranium Royalty pay a dividend?

Not currently.

Is Uranium Royalty a good stock to buy?

We do not give buy or sell advice. Uranium Royalty scores 2.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.